Final height in congenital adrenal hyperplasia: the dilemma of hypercortisolism versus hyperandrogenism (Q45005924)

8 December 2017

Final height in congenital adrenal hyperplasia: the dilemma of hypercortisolism versus hyperandrogenism (English)

1 reference

congenital adrenal hyperplasia

8 December 2017

1 reference

based on heuristic

inferred from title

author name string

Giovana Vignoli Cordeiro

1

1 reference

8 December 2017

Ivani Novato Silva

2

1 reference

8 December 2017

Eugênio Marcos Andrade Goulart

3

1 reference

8 December 2017

Antônio José das Chagas

4

1 reference

8 December 2017

Cláudio Elias Kater

5

1 reference

8 December 2017

1 March 2013

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

8 December 2017

1 reference

8 December 2017

57

1 reference

8 December 2017

126-131

1 reference

8 December 2017

2

1 reference

Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency

8 December 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Growth and reproductive outcomes in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Back to basics: early diagnosis and compliance improve final height outcome in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

New ideas for medical treatment of congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Final adult height in children with congenital adrenal hyperplasia treated with growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Growth, development, and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Impairment in anthropometric parameters and body composition in females with classical 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Bioelectrical impedance analysis of body fatness in childhood congenital adrenal hyperplasia and its metabolic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the "growth toxic" glucocorticoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000200005

10.1590/S0004-27302013000200005

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference